Skip to content

Effect of Shigrvadi Kashaya and Panchvalkala Kashaya in PID

Effect of Shigrvadi Kashaya and Panchvalkala Kashaya in Pelvic Inflammatory Diseases - PID

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/05/025395
Enrollment
35
Registered
2020-05-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N00-N99- Diseases of the genitourinary system

Interventions

Intervention1: Shigrvadi Kashaya and Panchvalkala kashaya: Panchavalkala Kashaya 500 ml OD for yoniprakshalana for 7 days and Shigrvadi Kashaya 40 ml BD for oral administration for 60 days Control Int

Sponsors

Department of Prasuti Tantra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Married females, patient with age group of 20-50 year, with complaint of lower abdominal pain,unusual vaginal discharges, pain during coitus, menstrual irregularities, fever and associated symptoms of PID

Exclusion criteria

Exclusion criteria: unmarried, pregnant women, patient suffering from systemic diseases, patient having history of any drug allergy and psychological disorders, patient having any specific pathology of genital tract like benign or malignant tumor, tubo-ovarian abscess, erosion of cervix etc., patient suffering from any disease of external genital organs like eczema, vulvovaginitis etc., patient who is participating in any other research study

Design outcomes

Primary

MeasureTime frame
assessment will be done on the basis of prepared pro forma and improvement in the sign and symptoms of Pelvic Inflammatory DisesesTimepoint: Treatment will be started in post menstrual period, 5 follow up will be done at interval of 15 days

Secondary

MeasureTime frame
Improvement in criteria listed in scales for pain-VAS scale, vaginal discharges, amount of menstrual blood loss, dyspareunia,duration of menstrual blood loss, intermenstrual period, cervical motion tenderness, fornices tenderness, adnexal tenderness, PAP smear findings, USG pelvis findings, associated symptoms.Timepoint: Treatment will be started in post menstrual period, 5 follow up will be done at interval of 15 days

Countries

India

Contacts

Public ContactDr Vishwesh B N

Banaras Hindu University

vishweshbn@gmail.com9454950602

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026